TABLE 1

Respondent Characteristics (N = 35)

CharacteristicN (%)
Sex
 Male25 (71)
 Female10 (29)
Age group, y
 <405 (14)
 40–499 (26)
 50–5912 (34)
 60–699 (26)
Country of practice
 High-income countries
  Australia5 (14)
  Canada5 (14)
  Finland1 (3)
  France1 (3)
  United Kingdom3 (5)
  United States5 (14)
 LMICs
  India5 (14)
  Nigeria4 (11)
  Papua New Guinea1 (3)
  South Africa5 (14)
Rolea
 Researchers/cliniciansb30 (50)
 Regulatorsc20 (33)
 Sponsord10 (17)
Specialty areaa
 General pediatrics13 (21)
 Subspecialitye46 (72)
 Other3 (5)
Clinical trial experience, y
 <1013 (37)
 10–2011 (31)
 21–307 (20)
 >304 (11)
  • a Numbers do not equal 35 because multiple categories apply to some individuals.

  • b Researchers: academic, administrator, clinicians/pediatrician, clinical pharmacologist, investigators/researcher, methodologist, networks/working groups, clinical trials center/clinical research facility, and trial coordinators/assistants.

  • c Regulators: institutional review board (bioethicist, ethics committee member, ethical review bodies, ethics subcommittee/scientific advisory committee member), networks/working groups, Data Safety Monitoring Board or Data Monitoring Committee/local safety monitor, regulatory body, policy makers, and research governance.

  • d Sponsors: academic sponsor, charitable organizations, clinical research assistants, government funding body, monitors, pharmaceutical industry, contract research organization, and consultancy work with sponsors.

  • e Number of respondents in subspecialties were as follows: cardiology, n = 1; clinical pharmacology, n = 2; emergency, n = 1; endocrinology, n = 2; immunology and infectious disease, n = 8; intensive care, n = 3; hematology, n = 3; neonatology, n = 7; nutrition, n = 1; oncology, n = 8; psychological medicine or mental health, n = 2; renal, n = 3; respiratory, n = 4; and musculoskeletal or rheumatology, n = 1. Other: ethics, n = 1; methodology, n = 2.